Bromide

Bromide

SCHEMBL9661615

COc1ccc(CCC[n+]2ccn(C)c2)cc1.[Br-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CALM1 P0DP23 1/20 0.44
▸ IGF1R P08069 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ SIGMAR1 Q99720 2/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.41
▸ MAOB P27338 3/20 0.41
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ CHRNA7 P36544 1/20 0.39
▸ CHRNA10 Q9GZZ6 1/20 0.39
▸ CHRNA9 Q9UGM1 1/20 0.39
▸ ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9663315 0.83 MEN1 (0.40) CALM1IGF1RALOX15SIGMAR1
Bromide SCHEMBL2196193 0.82 SIGMAR1 (0.40) ALOX15SIGMAR1HRH3MAOBGSK3A
Bromide SCHEMBL9661598 0.81 MEN1 (0.47) —
SCHEMBL1009270 0.80 SIGMAR1 (0.41) ALOX15SIGMAR1HRH3MAOBGSK3A
SCHEMBL869647 0.80 SIGMAR1 (0.41) SIGMAR1CHRNA7CHRNA10CHRNA9
Bromide SCHEMBL9663305 0.80 MEN1 (0.40) CALM1IGF1RALOX15SIGMAR1HRH3
Hydrochloric Acid SCHEMBL5835817 0.79 SIGMAR1 (0.40) SIGMAR1CHRNA7CHRNA10CHRNA9
Bromide SCHEMBL9661590 0.78 CA1 (0.45) —
Bromide SCHEMBL9663744 0.77 MEN1 (0.46) IGF1RALOX15
Bromide SCHEMBL9663747 0.77 MEN1 (0.46) IGF1RALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131302-B1 IMIDAZOLIUM SALTS, INTERMEDIATES THERETO AND THEIR USE SCHERING AKTIENGESELLSCHAFT (DE) 1992-01-29 — — EP disclosed
US-4689341-A Antiarrhythmic imidazoles SCHERING A.G. (DE) 1987-08-25 — — US disclosed
US-4613609-A Antiarrhythmic imidazoliums SCHERING A. G. (DE) 1986-09-23 — — US disclosed
US-4581370-A Antiarrhythmic imidazoliums SCHERING A.G. (DE) 1986-04-08 — — US disclosed
EP-0131302-A2 Imidazolium salts, intermediates thereto and their use SCHERING AKTIENGESELLSCHAFT (DE) 1985-01-16 — — EP disclosed
Send feedback